Parr Mcknight Wealth Management Group LLC Takes $1.68 Million Position in Danaher Co. (NYSE:DHR)

Parr Mcknight Wealth Management Group LLC acquired a new stake in Danaher Co. (NYSE:DHR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 7,329 shares of the conglomerate's stock, valued at approximately $1,682,000.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in Danaher by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate's stock worth $13,715,641,000 after purchasing an additional 315,912 shares during the period. Geode Capital Management LLC raised its holdings in shares of Danaher by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate's stock valued at $3,056,996,000 after buying an additional 315,446 shares during the last quarter. Norges Bank acquired a new stake in shares of Danaher during the fourth quarter worth about $2,130,740,000. Bank of New York Mellon Corp grew its holdings in shares of Danaher by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate's stock worth $1,971,609,000 after buying an additional 441,012 shares during the last quarter. Finally, Northern Trust Corp increased its position in Danaher by 14.3% in the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock valued at $1,821,477,000 after acquiring an additional 992,594 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

NYSE:DHR traded up $0.96 during mid-day trading on Wednesday, hitting $190.14. 1,193,072 shares of the company's stock traded hands, compared to its average volume of 3,464,499. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a market cap of $136.08 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm's 50 day simple moving average is $194.08 and its 200 day simple moving average is $214.67.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.67%. Danaher's dividend payout ratio is presently 24.85%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Jefferies Financial Group dropped their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research note on Tuesday, April 22nd. HSBC reduced their price objective on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price on the stock in a research report on Friday, March 14th. Finally, Barclays raised their price target on Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a report on Tuesday, April 22nd. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $263.24.

Insider Activity at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.